Skip to content
Back to Startups
A

Astratus

Astratus develops rapid testing technology to combat antimicrobial resistance.

Reading, UK Founded 2024
£385KTotal raised

Astratus is a University of Reading spin-out developing rapid microbiology testing technology to accelerate personalised antimicrobial prescribing.


Filed accounts

Cash at bank

Members only

Net current assets

Members only

Total assets less current liabilities

Members only

Net assets

Members only

Shareholders' funds

Members only

Fixed assets

Members only

Cash, assets and headcount from Astratus's latest Companies House filing — with year-on-year movement, free with a Winfred account.


Categories

BioTechHealthTech

Investors


Funding history